Tempus ECG-Low EF vs FibriCheck

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Tempus
VS
by FibriCheck

AI Verdict

Tempus ECG-Low EF is an AI software designed for clinical diagnostic settings, aiding healthcare professionals in identifying patients at risk of heart failure by analyzing 12-lead ECGs for low left ventricular ejection fraction. FibriCheck, conversely, is a patient-facing mobile application for remote heart rhythm monitoring, primarily detecting arrhythmias using smartphone PPG technology. While both leverage AI for cardiac health, their distinct focus on specific conditions, data input methods, and deployment models make them suitable for different use cases within cardiology.

Choose Tempus ECG-Low EF if…

Choose Tempus ECG-Low EF if your healthcare facility needs an FDA-cleared AI solution to screen patients aged 40 or older for signs associated with low left ventricular ejection fraction using standard 12-lead ECGs. This tool is ideal for integrating into existing clinical diagnostic workflows to aid clinicians in identifying patients at risk of heart failure for further evaluation.

View Tempus ECG-Low EF →

Choose FibriCheck if…

Choose FibriCheck if you require a patient-centric, remote monitoring solution for heart rhythm detection and ongoing arrhythmia management using a smartphone. This app is best suited for empowering patients to self-monitor their heart rhythm outside of a clinical setting, with the option for healthcare providers to oversee and customize monitoring rules.

View FibriCheck →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Tempus ECG-Low EF FibriCheck
Pricing Unknown Subscription-based, with options for monthly or annual payments. prices vary by region and may be partly or fully covered by insurance or employer.
Deployment Integrates with current ECG platforms and electronic health records (EHRs). Cloud-based (private cloud).
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

FibriCheck

FibriCheck offers a highly accessible patient-facing mobile application that leverages a smartphone camera for monitoring, making it extremely convenient for end-users. While Tempus integrates into existing clinical workflows, FibriCheck's dual approach with a patient app and a professional portal provides broader and more flexible usability.

Clinical Value

Tempus ECG-Low EF

Tempus ECG-Low EF provides a diagnostic aid for a critical, often asymptomatic condition (low LVEF) using a standard 12-lead ECG in a clinical setting, potentially enabling earlier intervention for heart failure risk. FibriCheck offers valuable arrhythmia monitoring for patients, but Tempus's application addresses a more profound diagnostic gap in the clinical workflow for a severe condition.

Pricing & Value

FibriCheck

FibriCheck provides transparent and detailed pricing models for both end-users and healthcare providers, including subscription options and short-term access. Tempus ECG-Low EF requires contacting the vendor for pricing, which makes it difficult to assess its value proposition without direct engagement.

Enterprise Readiness

Tempus ECG-Low EF

Tempus ECG-Low EF explicitly states integration into healthcare facility workflows, HIPAA compliance, BAA availability, and FDA clearance, indicating a strong focus on enterprise adoption. While FibriCheck also has HIPAA and FDA clearance and offers provider licensing, Tempus's direct emphasis on workflow integration and explicit BAA gives it a slight edge for large-scale institutional deployment.

Innovation

Tempus ECG-Low EF

Tempus ECG-Low EF demonstrates significant diagnostic innovation by using AI to detect signs of low LVEF from a standard 12-lead ECG, a capability that traditionally requires more complex imaging. While FibriCheck's smartphone-based PPG is also innovative for remote monitoring, Tempus's approach offers a novel diagnostic pathway for a critical cardiac condition.

Support & Docs

FibriCheck

FibriCheck offers readily accessible public support resources, including a dedicated help center with FAQs and user guides for both patients and professionals. Tempus, as an enterprise solution, provides customer support to its clients via email and dedicated representatives, but FibriCheck's transparent and easily discoverable documentation and support channels for a broader user base give it an advantage in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Tempus ECG-Low EF FibriCheck
Product Name Tempus ECG-Low EF FibriCheck
Company Tempus AI Qompium nv
Primary Detection Focus Detects signs associated with low Left Ventricular Ejection Fraction (LVEF u226440%) Detect and monitor arrhythmias (e.g., Atrial Fibrillation (AFib))
Technology Used AI software analyzes 12-lead ECG recordings Smartphone camera-based PPG technology, AI-powered algorithm
Target User/Setting Clinicians in clinical diagnostic settings at healthcare facilities, for patients 40+ years at risk of heart failure Patients (end-users) for self-monitoring; healthcare providers and clinical centers for patient monitoring

Videos

Demos, reviews, and walkthroughs featuring Tempus ECG-Low EF and FibriCheck.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tempus ECG-Low EF is an FDA-cleared AI software designed to analyze 12-lead ECGs to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. FibriCheck is a medically certified app that helps patients monitor their heart rhythm to detect and monitor arrhythmias, such as Atrial Fibrillation, using their smartphone.
Tempus ECG-Low EF analyzes resting, non-ambulatory 12-lead ECG recordings collected at a healthcare facility. FibriCheck uses smartphone camera-based photoplethysmography (PPG) technology for heart rhythm measurement.
Tempus ECG-Low EF provides a binary output: 'Low LVEF Detected' or 'Not Detected', intended to aid clinicians in further evaluation for low LVEF. FibriCheck offers immediate and actionable results regarding arrhythmia detection and analysis, accessible through a healthcare professional portal.
Tempus ECG-Low EF is for use in clinical diagnostic settings at healthcare facilities for patients 40 years or older at risk of heart failure. FibriCheck is designed for patients to monitor their heart rhythm at home using their smartphone, with a portal for healthcare providers to monitor them remotely.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.